Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Copyright 2026 NPR
Merck and Moderna announced a successful late-stage trial for a melanoma vaccine. NPR's Leila Fadel talks to Dr. Robert Vonderheide of Penn Medicine and the American Association for Cancer Research.
Copyright 2026 NPR
The biggest portion of Boise State Public Radio's funding comes from readers like you who value fact-based journalism and trustworthy information.
Your donation today helps make our local reporting free for our entire community.